Studies
List of Studies being conducted at CARE
Comet
Enrolling, Heart Failure
This trial is looking at the medication Omecamtiv Mecarbil (OM for short) in patients with severely reduced ejection fraction (pumping…
Pfizer Obesity
Weight Loss, Enrolling
This study is looking at a once daily pill (PF-07976016) in combination with Liraglutide which is an approved GLP-1R agonist in patients…
Kardia-3
Enrolling, Hypertension
The purpose of this study is to evaluate the effect of zilebesiran as add-on therapy in patients with high cardiovascular risk and…
MUIR-3
In Follow Up, High Triglyceride
This Phase 3 study will evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) in adult participants with hypertriglyceridemia…
Redefine-3
Enrolling, Weight Loss
This study will look at the effects of CagriSema on cardiovascular events (for example heart attack and stroke) in people living with…
Shasta-4
Enrolling, High Triglyceride
This Phase 3 study will evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) in adult participants with severe…
BalanceD-HF
Enrolling, Heart Failure
The purpose of this study is to investigate the effect of balcinrenone/dapagliflozin compared with dapagliflozin, on the risk of CV death…
Triumph
Enrolling, Weight Loss
The main purpose of this study is to evaluate the efficacy and safety of retatrutide once weekly in participants with obesity and…
Tandem
In Follow Up, Cholesterol
The study is a placebo-controlled, double-blind, randomized, phase 3 study in participants with heterozygous familial hypercholesterolemia…
Tharros
Enrolling, COPD
THARROS is the first-ever prospective trial to investigate the potential of an inhaled triple therapy to reduce cardiopulmonary events, a…
Acclaim
Enrolling, Lipoprotein (a)
The purpose of this study is to evaluate the efficacy of lepodisiran in reducing cardiovascular risk in participants with high lipoprotein(a…
V-Prevent
In Follow Up, Cholesterol
The purpose of this study is to evaluate inclisiran sodium 300 mg s.c. (equivalent to 284 mg inclisiran) compared to placebo on reducing the…